Retina-on-a-chip model to study eye disease
ScienceDaily - 27-Aug-2019Will tell us about the new drugs that can cause blindness
Join the club for FREE to access the whole archive and other member benefits.
Postdoctoral reseaarcher at the Eberhard Karls University Tubingen.
Dr. Kevin Achberger is a postdoctoral fellow and group leader at the Institute of Neuroanatomy and Developmental Biology (INDB) at the Eberhard Karls University Tübingen, Germany.
He graduated from the Ulm University in 2013 with a Master of Science in Molecular Medicine. In 2019, he completed his PhD in neurosciences at the University of Tübingen with his research work entitled Human retinal organoids- Exploration of a human induced pluripotent stem cell- derived in vitro model on Retinitis Pigmentosa. Since then his research projects have focused on the use of induced pluripotent stem cell-derived retinal organoid technology as a disease model and drug screening platform.
Visit website: https://retina.ie/dr-kevin-achberger/
See also: Eberhard Karls University of Tubingen - Public Research university.
Details last updated 16-Nov-2019
Will tell us about the new drugs that can cause blindness